GSK-CureVac’s 2nd Covid vax shows better immune response
Berlin, Aug 17 : The second mRNA Covid-19 Vaccine developed by German biopharmaceutical company CureVac and its British partner GlaxoSmithKline (GSK) has demonstrated improved immune response and protection than its first vaccine, according to a new …